Clinical Trial Update: Comparison Between Rituximab Treatment and General Corticotherapy Treatment in Patients With Pemphigus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing rituximab to general corticosteroid therapy in pemphigus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pemphigus

Drugs mentioned

• PREDNISONE (Prednisone)
• Rituximab (rituximab)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Pemphigus Disease | Phase 3 | Status: COMPLETED